RecruitingNCT04407780

Cardio-Oncology Registry

Cardio-Oncologie: étude Pilote évaluant la faisabilité, Utilité Concrète, Interdisciplinaire d'Une Unité Spécialisée


Sponsor

European Georges Pompidou Hospital

Enrollment

5,000 participants

Start Date

Jan 1, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Cardio-oncology is an emerging field. Most of the data available have been issued from either retrospective analysis, industry data or pharmacovigilance data. These data sources include a number of bias. CONFUCIUS is a single tertiary centre prospective registry including all patients who have been referred for cardio-oncology assessemnt. The objectives are to provide a comprehensive vue of cardoi-oncology, enable to detect early signals of cardiotoxicity and enhance ancillary projetcts aiming at specific populations (e.g., type of cancer) and/or drugs.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • referred to cardio-oncology

Exclusion Criteria1

  • refusal to participate

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo interventions are planned

Non applicable


Locations(1)

Assistance Publique Hôpitaux de Paris - Centre Université de Paris

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04407780


Related Trials